secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001829126-25-000765
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 5.07, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel raises up to $33M via Lazar & Helena equity lines; stockholders approve reverse split and share increases
--------------------------------------------------------------------------------

- Lazar purchase agreement: up to $8M in Common Stock, exercisable by company until Sept 30, 2026, in $1M/$2M increments.
- Helena equity line: up to $25M over 36 months; initial commitment shares $125K; purchases at 95% of VWAP, min stock price $0.20.
- Amended Armistice exchange: $1.1M cash deferred to Q1 2025 filing; additional 100,000 shares issued subject to stockholder approval (received).
- Stockholders approved reverse stock split (1:4 to 1:16), authorized shares increase to 250M, and issuances to Lazar and Armistice.
- Company believes it has regained Nasdaq minimum stockholders' equity of $2.5M after these transactions and Cyclacel Ltd. deconsolidation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625000765/0001829126-25-000765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000182912625000765/cyclacel_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-25-000765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer